TREA

79387958 - RIBORENOSTAR

Follow

Information

  • Trademark
  • 79387958
  • Serial Number
    79387958
  • Filing Date
    November 10, 2023
    a year ago
  • Transaction Date
    January 28, 2025
    25 days ago
  • Status Date
    January 28, 2025
    25 days ago
  • Published for Opposition Date
    January 28, 2025
    25 days ago
  • Location Date
    January 06, 2025
    a month ago
  • Status Code
    686
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    MASON,JARED MICHAEL
  • Attorney Docket Number
    20700.0463US
    Attorney Name
    Zhi Dong
    Law Office Assigned Location Code
    N10
  • Owners
Information
Mark Drawing Code
4
Mark Identification
RIBORENOSTAR
Case File Statements
  • GS0051: Medicines for humans for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; crude drugs being pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; chemico-pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; biological preparations for medical purposes for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; chemical preparations for pharmaceutical purposes for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; chemical preparations for medical purposes for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; drugs for medical purposes, namely, pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; diagnostic preparations for medical purposes; potassium salts for medical purposes; sodium salts for medical purposes; pharmaceuticals for the treatment of cancer; anti-cancer preparations; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the prevention and treatment of cancer; tumor suppressing agents; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the central nervous system; pharmaceuticals for the treatment of infectious diseases; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; anticoagulants; cardiovascular pharmaceuticals; pharmaceutical preparations for ocular or intraocular surgery; dietetic food and beverages adapted for medical use; depuratives for the body; medicines for veterinary purposes, namely, veterinary preparations for the treatment and diagnosis of gastrointestinal diseases, cardiovascular diseases, metabolic diseases, and liver diseases; pesticides; dressings, medical; composite materials for dental purposes; diapers for pets
  • PM0001: RIBO RENO STAR
  • GS0421: Technological research in the field of pharmaceutical manufacturing processes and pharmaceutical studies; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation; pharmaceutical research and development services; research in the field of pharmaceuticals; scientific research; chemical research and analysis; development and testing of chemical production methods; biochemical research and analysis; scientific research in the nature of conducting clinical trials for others; medical research; testing of pharmaceuticals; industrial design
Case File Event Statements
  • 6/18/2024 - 8 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/20/2024 - 8 months ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/21/2024 - 8 months ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 7/11/2024 - 7 months ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 7/11/2024 - 7 months ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 1/25/2024 - a year ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 1/26/2024 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/30/2024 - a year ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 12/30/2024 - a month ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/30/2024 - a month ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/30/2024 - a month ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/2/2025 - a month ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 1/2/2025 - a month ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 1/2/2025 - a month ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 1/2/2025 - a month ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/2/2025 - a month ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 1/22/2025 - a month ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/28/2025 - 25 days ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/28/2025 - 25 days ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/28/2024 - 6 months ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT